Article
Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.
Journal of virology - 1 Dec 2014
Sui Jianhua, Deming Meagan, Rockx Barry, Liddington Robert C, Zhu Quan Karen, Baric Ralph S, Marasco Wayne A
Abstract excerpt
UNLABELLED: The receptor binding domain (RBD) of the spike (S) glycoprotein of severe acute respiratory syndrome coronavirus (SARS-CoV) is a major target of protective immunity in vivo. Although a large number of neutralizing antibodies (nAbs) have been developed, it remains unclear if a single RBD-targeting nAb or two in combination can prevent neutralization escape and, if not, attenuate viral virulence in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
